KYLE LIANG: Open Payments
NPI 1497304034 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$995 in 26 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $421 · 2025 $995
Food & beverage: $995
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 17 | $717 |
| Janssen Biotech, Inc. | 6 | $208 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $26 |
| Olympus America Inc. | 1 | $25 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
Products named: EXALT Model D, TREMFYA, OverStitch Endoscopic Suturing System, WallFlex Duodenal, SpyGlass, Agile Esophageal, Axios, ENTYVIO.
Industry payments across NY — which companies pay providers there.
